Trial Profile
A phase 1, randomized, double-blind, single-center, placebo-controlled study to evaluate the safety, tolerability and pharmacokinetics of ascending single oral doses of XW10172 in healthy adult subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Aug 2021
Price :
$35
*
At a glance
- Drugs Valiloxybate (Primary)
- Indications Narcolepsy
- Focus Adverse reactions
- Sponsors XW labs; XWPharma
- 27 May 2019 Status changed from recruiting to completed.
- 06 Jun 2018 Planned End Date changed from 22 Jun 2018 to 2 Aug 2018.
- 06 Jun 2018 Status changed from not yet recruiting to recruiting.